Brief: Shanghai Bio-Heart Biological Technology To Make Capital Injection Into Cardiotek (Beijing)
Sept 5 (Reuters) - Shanghai Bio-heart Biological Technology
Co Ltd 2185.HK :
* TO MAKE A CAPITAL INJECTION OF RMB50 MILLION INTO
CARDIOTEK
(BEIJING) MEDICAL TECHNOLOGY
* UPON COMPLETION, CO WILL HOLD ABOUT 9.09% EQUITY INTEREST
IN
CARDIOTEK
Source text for Eikon: ID:nHKS5Y8S0j
Further company coverage: 2185.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Bio-heart Biological Technology
See all newsBrief: Shanghai Bio-Heart Biological Technology Says NMPA Approves Bioheart Bioabsorbable Drug-Eluting Stents
Brief: Shanghai Bio-Heart Biological Technology Says Iberis Rdn System Completes Registration In Vietnam
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completed Registration In Thailand
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completes Registration With MHRA In UK
Brief: Shanghai Bio-Heart Biological Technology's Controlling Shareholder Increases Shareholding